| 000 | 01968naaaa2200325uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/57723 | ||
| 005 | 20220220030149.0 | ||
| 020 | _aintechopen.73801 | ||
| 020 | _a9781838801519 | ||
| 020 | _a9781838806415 | ||
| 020 | _a9781838801526 | ||
| 024 | 7 |
_a10.5772/intechopen.73801 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aRobert B Laprairie _4auth |
|
| 700 | 1 |
_aWillard J Costain _4auth |
|
| 245 | 1 | 0 | _aRecent Advances in Cannabinoid Research |
| 260 |
_bIntechOpen _c2019 |
||
| 300 | _a1 electronic resource (230 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aScientific interest in cannabinoid research is currently experiencing a significant increase because of changing attitudes toward Cannabis and the evolving awareness of its pharmaceutical benefits. Coincidently, numerous jurisdictions are moving toward legalizing Cannabis and Cannabis-derived products, which reflects a larger global movement to understand Cannabis and its bioactive chemicals for their potential biomedical uses, harms, and economic value. Research activities are surging to fill important knowledge gaps in the field of cannabinoids as they continue to be identified. The purpose of this book is to summarize some leading areas of research in the cannabinoid field where knowledge gaps are actively being addressed. The research described herein spans basic biological and clinical research. | ||
| 540 |
_aAll rights reserved _4http://oapen.org/content/about-rights |
||
| 546 | _aEnglish | ||
| 653 | _aLife Sciences | ||
| 653 | _aNeurochemistry | ||
| 653 | _aNeuroscience | ||
| 653 | _aMolecular Neuroscience | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://www.intechopen.com/books/recent-advances-in-cannabinoid-research _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/57723 _70 _zDOAB: description of the publication |
| 999 |
_c61045 _d61045 |
||